Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model.
A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies.
Postnatal lethality and abnormal development of foregut and spleen in Ndrg4 mutant mice.
Walking execution is not affected by divided attention in patients with multiple sclerosis with no disability, but there is a motor planning impairment.
How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
Lymphocytic hypophysitis associated with pediatric multiple sclerosis.
Antibody patterns vary arbitrarily between cerebrospinal fluid and aqueous humor of the individual multiple sclerosis patient: Specificity-independent pathological B cell function.
Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype.
Serostatus of Epstein-Barr virus in Iranian MS patients.
Molecular basis of axonal dysfunction and traffic impairments in CMT.
A Feasibility Study to Investigate the Effect of Functional Electrical Stimulation and Physiotherapy Exercise on the Quality of Gait of People With Multiple Sclerosis.
Risk of Demyelinating Diseases in the Central Nervous System in Patients With Inflammatory Bowel Disease Treated With Tumor Necrosis Factor Inhibitors.
Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
Improved Characterization of Visual Evoked Potentials in Multiple Sclerosis by Topographic Analysis.
Central nervous system infectious diseases mimicking multiple sclerosis: recognizing distinguishable features using MRI.
Sexual Dysfunction in Male Patients with Multiple Sclerosis: A Need for Counseling!
Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence.
Thoughts of death and self-harm in patients with epilepsy or multiple sclerosis in a tertiary care center.
Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia.
Smoking worsens multiple sclerosis prognosis: Two different pathways are involved.
Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes.
Progressive Multifocal Leukoencephalopathy.
Neuroprotective Effects of Endurance Exercise against High Fat Diet-Induced Hippocampal Neuroinflammation.
Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis.
The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease.
Pages
« first
‹ previous
…
685
686
687
688
689
690
691
692
693
…
next ›
last »